Gary Charles Robb, Chief Business Officer at CORCEPT THERAPEUTICS INC (CORT), sold 109,194 shares at $20.49 ($2.2M) on 2021-09-15, disclosed to the SEC on 2021-09-15.
Open-market sale of $2.2M CORT by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.89 | 6,341 | $132K | 5.9% |
| 2 | $20.89 | 6,341 | $132K | 5.9% |
| 3 | $20.76 | 806 | $17K | 0.7% |
| 4 | $20.49 | 47,853 | $981K | 43.7% |
| 5 | $20.49 | 47,853 | $981K | 43.7% |
| Total | $20.54 avg | 109,194 |
| $2.2M |
| 100% |
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |